INBRAIN Neuroelectronics
INBRAIN Neuroelectronics is dedicated to developing breakthrough neuroelectronic therapies using graphene-based neural interfaces. Their mission is to decode and modulate the brain and entire neural system to improve lives through innovative, minimally invasive, and intelligent neurotechnology. Recognized as a 2025 Technology Pioneer by the World Economic Forum, INBRAIN is pioneering a new class of brain-computer interfaces to treat neurological disorders with unprecedented precision, leveraging graphene's unique properties for high-resolution, safe, scalable therapies.
Industries
Nr. of Employees
small (1-50)
INBRAIN Neuroelectronics
Barcelona, Catalonia, Spain, Europe
Products
Graphene-based high-density implantable neural interface platform (development-stage)
A platform combining flexible graphene-based microelectrodes, an implantable processing unit with wireless rechargeable power, and AI-enabled closed-loop software to decode and modulate neural circuits.
Graphene-enabled bioelectronic vagus nerve therapy development (collaborative project)
Development-stage program focusing on selective neurostimulation of the vagus nerve using graphene electrodes to enable targeted treatment of inflammatory, metabolic and endocrine disorders.
Graphene-based high-density implantable neural interface platform (development-stage)
A platform combining flexible graphene-based microelectrodes, an implantable processing unit with wireless rechargeable power, and AI-enabled closed-loop software to decode and modulate neural circuits.
Graphene-enabled bioelectronic vagus nerve therapy development (collaborative project)
Development-stage program focusing on selective neurostimulation of the vagus nerve using graphene electrodes to enable targeted treatment of inflammatory, metabolic and endocrine disorders.
Services
Development of graphene-based brain-computer interface therapeutics
Research and engineering services to design high-density, graphene-enabled implantable neural interfaces and supporting software for real-time decoding and neuromodulation.
Co-development of bioelectronic vagus nerve therapies
Collaborative development service to create targeted bioelectronic therapies for chronic diseases using graphene-enabled interfaces and signal processing expertise.
Regulatory and clinical translation support for implantable neurodevices
Advisory and operational support covering regulatory strategy, quality systems, and clinical affairs aimed at device translation and early-stage clinical evaluation.
Development of graphene-based brain-computer interface therapeutics
Research and engineering services to design high-density, graphene-enabled implantable neural interfaces and supporting software for real-time decoding and neuromodulation.
Co-development of bioelectronic vagus nerve therapies
Collaborative development service to create targeted bioelectronic therapies for chronic diseases using graphene-enabled interfaces and signal processing expertise.
Regulatory and clinical translation support for implantable neurodevices
Advisory and operational support covering regulatory strategy, quality systems, and clinical affairs aimed at device translation and early-stage clinical evaluation.
Expertise Areas
- Brain–computer interface development
- Closed-loop neuromodulation and AI-driven therapy personalization
- Graphene-based neuroelectrode materials and device engineering
- Implantable medical device hardware and embedded signal processing
Key Technologies
- Graphene-based microtransistor electrodes
- High-density microelectrode arrays
- Wireless implantable processors with rechargeable power
- AI-driven closed-loop neuromodulation algorithms